Matches in Nanopublications for { ?s ?p "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP226429.RAWyzd1B3FdEHefhT2ANUXQSAuVTC8-oX8zvxEViXPlgQ130_assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226429.RAWyzd1B3FdEHefhT2ANUXQSAuVTC8-oX8zvxEViXPlgQ130_provenance.
- NP526749.RAViN_aa6rN_sBd1Dzxlgqz-Or6FN_2ixsdP80LcMV6mc130_assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526749.RAViN_aa6rN_sBd1Dzxlgqz-Or6FN_2ixsdP80LcMV6mc130_provenance.
- assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP756182.RAKTajJrOMo2Nb1hO_LZdVvKKm5_pdpJgZYH6TE_wkPjw130_assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756182.RAKTajJrOMo2Nb1hO_LZdVvKKm5_pdpJgZYH6TE_wkPjw130_provenance.
- NP402437.RAmVy0rK9FhmmMSwmxKOJnPCx91yKIiMb9N8TZHEBBMM0130_assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402437.RAmVy0rK9FhmmMSwmxKOJnPCx91yKIiMb9N8TZHEBBMM0130_provenance.
- NP402438.RAma-CzbU9GQ5zWQDmJ9Z6Cfp3bKTSlMzPCuEWaZr9Eas130_assertion description "[These results indicate HK is proangiogenic probably by releasing bradykinin and that a monoclonal antibody directed to HK could serve as an antiangiogenic agent with a potential for inhibiting tumor angiogenesis and other angiogenesis-mediated disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402438.RAma-CzbU9GQ5zWQDmJ9Z6Cfp3bKTSlMzPCuEWaZr9Eas130_provenance.